Learning Needs Analysis Template Trainee Pharmacist

Standard Operating Procedure: Learning Needs Analysis (LNA) for Trainee Pharmacists

1. Document Control & Revision History

---

2. Executive Summary & Scope

2.1 Clinical Statement of Operational Boundaries

This Standard Operating Procedure (SOP) defines the mandatory operational workflow for conducting and documenting the Learning Needs Analysis (LNA) for trainee pharmacists (Foundation Pharmacists / pre-registration trainees). The LNA is the foundational diagnostic mechanism used to baseline a trainee's clinical competence, professional behaviors, and baseline knowledge against the GPhC Initial Education and Training (E&T) standards and the RPS Foundation Pharmacy Framework.

2.2 Regulatory Standards & Governance

Compliance with this SOP is compulsory across all operational sites housing trainee pharmacists. This procedure ensures adherence to:

• General Pharmaceutical Council (GPhC) Standards for the Pharmacy Education and Training of Pharmacists.
• Health Education England (HEE) / NHS England Foundation Pharmacist Curriculum requirements.
• ISO 9001 Quality Management Systems regarding competency validation and professional credentialing.

---

3. Prerequisites & Tool Requirements

Execution of this SOP requires the fulfillment of the following prerequisites prior to commencing the operational workflow:

• Hardware & Software Access:
  • Secure, encrypted workstation with multi-factor authentication (MFA).
  • Active access to the institutional Learning Management System (LMS) and e-Portfolio platform (e.g., Horus, BNF/BNFC online portals).
  • Clinical Governance incident reporting software access (e.g., Datix).
• Documentation & Templates:
  • Standardized LNA Template (Form LNA-TP-2025-v2).
  • Current GPhC Initial Education and Training Learning Outcomes.
• Certifications & Governance:
  • Designated Supervisor (DS) and/or Designated Practice Supervisor (DPS) status verified by the institutional Quality Lead.
  • Information Governance (IG) annual training certificate up to date for all participating parties.
  • Physical/Virtual private meeting environment ensuring strict confidentiality under Data Protection Act / GDPR protocols.

---

4. Roles & Responsibilities (RACI Matrix Table)

• Responsible (R): The role that performs the activity.
• Accountable (A): The role with final approval and fiduciary/regulatory accountability.
• Consulted (C): The role providing advisory input.
• Informed (I): The role kept updated on progress and completion.

---

5. Step-by-Step Operational Procedure

Phase 1: Pre-Assessment Data Aggregation (T-14 Days)

• 1.1 Securely retrieve the trainee pharmacist’s academic transcripts, UCAS/undergraduate performance indicators, and previous placement feedback reports from the HR/Training archive.
• 1.2 Issue the self-reflection precursor questionnaire (Form LNA-SR-01) to the trainee pharmacist via the secure e-Portfolio portal.
• 1.3 Verify that the trainee has completed mandatory baseline modules (e.g., Basic Life Support, Infection Control, and Data Protection).

Phase 2: Diagnostic Evaluation & Baseline Mapping (T-7 Days)

• 2.1 Conduct a diagnostic baseline assessment using standardized clinical scenarios mapped directly to GPhC learning outcomes (Person-centred care, Professional practice, Collaboration, Leadership).
• 2.2 Evaluate the trainee's self-assessment responses against objective clinical competency benchmarks to identify discrepancies between perceived and actual capability.
• 2.3 Populate Section 1 ("Baseline Knowledge & Skill Profile") of the LNA Template (Form LNA-TP-2025-v2).

Phase 3: Formal LNA Interview & Collaborative Goal Setting (Day 0)

• 3.1 Convene a formal, uninterrupted 60-minute diagnostic interview between the Trainee, DS, and/or DPS.
• 3.2 Review identified clinical gaps, psychological safety factors, learning style preferences (e.g., VARK model), and any specific accessibility or health requirements.
• 3.3 Co-create SMART (Specific, Measurable, Achievable, Relevant, Time-bound) learning objectives for the upcoming operational quarter.
• 3.4 Populate Section 2 ("Identified Gaps & Actionable Development Plan") of the LNA template.

Phase 4: Final Sign-Off & System Integration (T+2 Days)

• 4.1 Obtain electronic signatures from both the Trainee Pharmacist and the Designated Supervisor on the finalized LNA document.
• 4.2 Upload the completed Form LNA-TP-2025-v2 to the centralized e-Portfolio platform under the "Supervision & Assessment" tab.
• 4.3 Schedule automated calendar checkpoints for intermediate progress reviews (at T+30 and T+90 days).

---

6. Quality Assurance & Verification Criteria

6.1 Audit Checklist

• All mandatory fields in Form LNA-TP-2025-v2 are populated with verified data (no blank parameters or "N/A" entries without qualitative justification).
• Every identified learning gap maps directly to at least one GPhC learning outcome.
• Signatures and date stamps are fully authenticated within the e-Portfolio audit log.

6.2 Tolerance Thresholds & Acceptance Benchmarks

• Completion Timelines: The LNA process must be finalized and uploaded within 14 calendar days of the trainee's formal start date. Breaches require a formal variance report to the Director of Clinical Education.
• Objective Variance Acceptance: Discrepancies exceeding 30% between self-assessed competence and supervisor-observed diagnostic capability require mandatory mandatory escalation and immediate assignment of a targeted remediation plan.

---

7. Practical Troubleshooting Scenarios

Scenario A: Trainee Fails to Complete Pre-Assessment Diagnostic or Self-Reflection

• Diagnostic Indicators: Pre-assessment portal status shows 0% completion at T-3 days; trainee cites technical access issues or workload pressures.
• Immediate Corrective Action Protocol:
  1. Designated Supervisor issues an immediate automated system reminder via the LMS.
  2. If uncompleted at T-24 hours, the DS intervenes by conducting a verbal diagnostic triage during the scheduled interview slot, directly inputting data on behalf of the trainee while logging a minor compliance deviation note in the e-Portfolio.
  3. IT Helpdesk ticket is raised concurrently if technical access was the primary root cause.

Scenario B: Significant Discrepancy (Overestimation of Competence)

• Diagnostic Indicators: Trainee rates themselves as "Highly Competent" in high-risk domains (e.g., aseptic dispensing or clinical medication review), while diagnostic testing reveals baseline deficits or unsafe practice tendencies.
• Immediate Corrective Action Protocol:
  1. Pause the standard objective-setting phase of the interview.
  2. Present objective, anonymized benchmarking data to the trainee in a non-punitive, constructive manner.
  3. Re-align the LNA development plan to insert immediate shadowing and direct supervision checkpoints before independent practice is permitted in the specific domain.
  4. Document the safety intervention explicitly in Section 3 ("Risk Mitigation & Supervised Practice Mandates") of the LNA form.

Scenario C: Unidentified Learning Disability or Accessibility Requirement Disclosed During LNA

• Diagnostic Indicators: Trainee verbally discloses a previously undocumented neurodivergent profile or physical impairment impacting assessment performance.
• Immediate Corrective Action Protocol:
  1. Immediately halt standard timed diagnostic evaluations.
  2. Record the disclosure securely and signpost the trainee to the internal Occupational Health and Workplace Adjustments team.
  3. Amend the LNA timeline to allow for formal occupational health assessment and reasonable adjustments (e.g., extra time for written tasks, assistive software integration) without penalizing progression metrics.